Currently, there are 997.11M common shares owned by the public and among those 837.53M shares have been available to trade.
The company’s stock has a 5-day price change of -3.47% and -10.12% over the past three months. CARR shares are trading 22.33% year to date (YTD), with the 12-month market performance up to 22.59% higher. It has a 12-month low price of $53.13 and touched a high of $83.32 over the same period. CARR has an average intraday trading volume of 4.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.98%, -7.79%, and 3.52% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Carrier Global Corp (NYSE: CARR) shares accounts for 85.06% of the company’s 997.11M shares outstanding.
It has a market capitalization of $63.06B and a beta (3y monthly) value of 1.21. The stock’s trailing 12-month PE ratio is 18.36, while the earnings-per-share (ttm) stands at $3.83. The company has a PEG of 1.84 and a Quick Ratio of 0.82 with the debt-to-equity ratio at 0.88. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.97% over the week and 1.89% over the month.
Earnings per share for the fiscal year are expected to decrease by -7.85%, and 20.66% over the next financial year. EPS should grow at an annualized rate of 10.00% over the next five years, compared to -12.91% over the past 5-year period.
Looking at the support for the CARR, a number of firms have released research notes about the stock. Goldman stated their Buy rating for the stock in a research note on December 12, 2024, with the firm’s price target at $96. UBS was of a view on November 13, 2024 that the stock is Buy, while Stephens gave the stock Equal-Weight rating on October 16, 2024, issuing a price target of $75- $85. JP Morgan on their part issued Neutral rating on October 10, 2024.
